Dementia Drug: More Harm Than Help?
A new drug designed to treat Alzheimer's disease is making headlines, but not for the reasons you might think. Lecanemab, approved for private use in the UK, was initially celebrated for potentially slowing the progression of the disease. However, recent data from the U. S. paints a different pictur